Clinical trials
Spinocerebellar Ataxia Type 3 clinical trials
Below are recruiting spinocerebellar ataxia type 3 clinical trials, each written for real people, not researchers. We’re tracking 7 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07221292RecruitingPhase 3
Study of N-acetyl-L-leucine for CACNA1A disorders
This trial tests a potential treatment for people with CACNA1A disorders, which can cause movement problems, migraine, or seizures. The medication may help improve balance and coordination.
Baltimore, MarylandAges 4 years+ - NCT01060371Recruiting
Study of genetic causes of spinocerebellar ataxia
This study follows people with certain types of spinocerebellar ataxia (a group of conditions that cause progressive movement problems) to understand how the disease changes over time and how genes might influence it. It may help researchers learn more about these conditions and support future treatments.
Los Angeles, CaliforniaAges 6 years+ - NCT07288437Recruiting
Deep brain stimulation for SCA6 ataxia
This study tests if deep brain stimulation (putting a device in the brain to send mild electrical pulses) can improve balance and movement in people with spinocerebellar ataxia type 6 (SCA6), a genetic condition that causes trouble walking and coordination.
San Francisco, CaliforniaAges 21–89 - NCT05822908RecruitingPhase 1/Phase 2
Study drug VO659 for SCA1, SCA3, and Huntington disease
This early-phase study tests whether VO659 is safe and how the body processes it in people with certain genetic movement disorders (SCA1, SCA3, or Huntington disease). It may help researchers learn the right dose and whether the drug can be given safely.
CopenhagenAges 25–60 - NCT01793168Recruiting
Rare disease registry and history study
This study keeps a registry (a structured list) of people with rare diseases and may also track how the condition changes over time. It can help researchers better understand rare illnesses and find gaps in care, which may improve future treatments.
Sioux Falls, South DakotaAges Any age - NCT06267222Enrolling by invitation
Spinal electrical stimulation for spinocerebellar ataxia
This study tests a noninvasive electrical stimulation therapy applied to the spine to see if it can improve movement and coordination in people with spinocerebellar ataxia. It may help with walking and balance.
Rio de Janeiro, Rio de JaneiroAges 18–70 - NCT07136844Recruiting
Walking and arm movement study for nerve and muscle conditions
This study uses motion analysis to understand walking and arm function in adults with certain neurological or metabolic diseases. The goal is to find patterns that help doctors better manage these conditions.
LiègeAges 18 years+
Hear when a new Spinocerebellar Ataxia Type 3 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for spinocerebellar ataxia type 3?
- Yes. Clin2 currently lists 7 recruiting spinocerebellar ataxia type 3 studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a spinocerebellar ataxia type 3 trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a spinocerebellar ataxia type 3 trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.